Results Could Expand Donor Pool Significantly

Patients and surgeons from Northeastern Eye Institute participated in a study indicating that corneal transplants using tissue from older donors have similar rates of survival to those using tissue from younger donors. The five-year transplant success rate for recipients was the same, 86 percent, for transplants performed across the nation with corneas from donors ages 12 to 65 years and from donors ages 66 to 75. Because of this new finding, the donor age pool, currently limited to donors 65 and younger, should be expanded to include donors up to 75 years of age. These are the conclusions of a study funded by the National Eye Institute (NEI) of the National Institutes of Health and published in the April issue of Ophthalmology.

The availability of donor corneas has been adequate for the past 10 years in the United States, where more than 33,000 corneal transplants are performed each year. However, recent changes in Food and Drug Administration (FDA) regulations will likely cause a decrease in the supply of donated corneas. These new regulations require additional screening and testing of potential donors for contagious diseases, registration of eye banks, more detailed records and labels, and stricter quarantine procedures. In addition, many eye banks previously set the age limit for donors at 65 years or younger because some surgeons have been reluctant to use older corneas. The findings from the new study could lessen these restrictive policies.

"This pivotal study indicates that corneas from older individuals are just as successful when used for transplants as those from younger donors," said Thomas S. Boland, M.D., Northeastern Eye Institute Cornea Specialist. "These study results will expand the donor cornea pool and make the scheduling of transplant procedures easier for both surgeons and patients."

Northeastern Eye Institute is one of 80 sites that participated in the Cornea Donor Study (CDS) and helped bring together more than 1,101 participants and 105 surgeons from across the United States. Participants from Northeastern Eye Institute were between 40 and 80 years of age and were chosen for the study if they were in need of a corneal transplant for a corneal disease that put them at moderate risk for clouding of the transplanted cornea. After the transplant surgery, the participants were followed for five years. The transplant was considered a failure if a repeat corneal transplant was required or if the cornea was cloudy for at least three months. Donor corneas were provided by 43 participating eye banks. All donor corneas met Eye Bank Association of America standards for human corneal transplantation and were consistent with eye banks' tissue ratings of good to excellent quality.

"The pressure on eye banks to provide corneas is increasing," said Paul A. Sieving, M.D., Ph.D., director of the National Eye Institute. "The results of this study will expand the available donor pool and should persuade surgeons to use corneas from older donors. These changes will greatly benefit the growing number of individuals who need corneal transplants."

As a national leader in eyecare, Northeastern Eye Institute continues its longstanding tradition of excellence and specialization in corneal transplantation. Dr. Boland and Dr. Christopher S. Jordan, of NEI's Cornea Service, continue to be at the forefront of development of modern corneal transplant techniques. They have performed many endothelial transplants, which allow for small incision surgery and a much faster recovery time for many patients. Further advancements such as laser assisted corneal transplants are now ready to be performed. "It is very rewarding to be able to offer these new techniques to our transplant patients. These procedures offer a faster recovery time than ever" said Dr. Boland.

Overall, the demand for organs and tissue is greater than the supply available for transplantation. In the United States, the U.S. Department of Health and Human Services Health Resources and Services Administration (HRSA) oversees the federal government's Organ Donor Program. This program is designed to increase awareness of the critical need for organ and tissue donors. For more information, go to https://www.organdonor.gov.

Additional support for CDS was provided by: Eye Bank Association of America, Bausch & Lomb, Inc., Tissue Banks International, Vision Share, Inc., San Diego Eye Bank, The Cornea Society, Katena Products, Inc., ViroMed Laboratories, Inc., Midwest Eye-Banks (Michigan Eye-Bank, Illinois Eye-Bank), Konan Medical Corporation, Eye Bank for Sight Restoration, SightLife, Sight Society of Northeastern New York (Lions Eye Bank of Albany), and Lions Eye Bank of Oregon.

For further information about Northeastern Eye Institute or to
schedule an appointment, please contact our main office by email
or by phone at (570) 342-3145 or800-334-2233.